Home Cart Sign in  
Chemical Structure| 126054-77-1 Chemical Structure| 126054-77-1

Structure of Atractyloside A
CAS No.: 126054-77-1

Chemical Structure| 126054-77-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Atractyloside A is a natural TCM reference compound.

Synonyms: Atractyloside A

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Atractyloside A

CAS No. :126054-77-1
Formula : C21H36O10
M.W : 448.50
SMILES Code : O=C1[C@@](C)(O)[C@]2([H])C[C@H](C(C)(O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)C)CC[C@@](CO)(O)[C@@]2([H])C1
Synonyms :
Atractyloside A
MDL No. :MFCD16621069
InChI Key :QNBLVYVBWDIWDM-BSLJOXIBSA-N
Pubchem ID :71307451

Safety of Atractyloside A

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
A549 cells 30 µM 24 h Evaluate the cytotoxicity of Atractyloside A on A549 cells Front Microbiol. 2023 Jan 10;13:1067725
MDCK cells 75 µM, 100 µM, 150 µM 24 h Evaluate the inhibitory effect of Atractyloside A on influenza B virus infection Front Microbiol. 2023 Jan 10;13:1067725

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague Dawley (SD) rats Spleen-deficiency syndrome (SDS) rat model Oral 1.25, 2.5, or 5 mg/kg Daily administration for 7 days AA increased body weight, intestinal propulsion rate, MTL, GAS, and c-Kit levels, while decreasing gastric residual volume and intestinal tissue damage. AA protected the intestinal mucosal barrier by inhibiting the p38 MAPK pathway, improving gastrointestinal function. Front Pharmacol. 2020 Nov 20;11:583160
C57BL/6 mice Influenza B virus infection model Oral 10 mg/kg and 30 mg/kg 14 consecutive days Evaluate the in vivo inhibitory effect of Atractyloside A on influenza B virus infection Front Microbiol. 2023 Jan 10;13:1067725

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.23mL

0.45mL

0.22mL

11.15mL

2.23mL

1.11mL

22.30mL

4.46mL

2.23mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories